A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patients ; volume:10 ; number:1 ; day:12 ; month:11 ; year:2020 ; pages:1-9 ; date:12.2020
Scientific reports ; 10, Heft 1 (12.11.2020), 1-9, 12.2020
- Urheber
-
Kida, Daihei
Takahashi, Nobunori
Kaneko, Atsushi
Hirano, Yuji
Fujibayashi, Takayoshi
Kanayama, Yasuhide
Hanabayashi, Masahiro
Yabe, Yuichiro
Takagi, Hideki
Oguchi, Takeshi
Kato, Takefumi
Funahashi, Koji
Matsumoto, Takuya
Ando, Masahiko
Kuwatsuka, Yachiyo
Tanaka, Eiichi
Yasuoka, Hidekata
Kaneko, Yuko
Hirata, Shintaro
Murakami, Kosaku
Sobue, Yasumori
Nishiume, Tsuyoshi
Suzuki, Mochihito
Yokota, Yutaka
Terabe, Kenya
Asai, Shuji
Ishiguro, Naoki
Kojima, Toshihisa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-76842-4
- URN
-
urn:nbn:de:101:1-2020122013465839074108
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kida, Daihei
- Takahashi, Nobunori
- Kaneko, Atsushi
- Hirano, Yuji
- Fujibayashi, Takayoshi
- Kanayama, Yasuhide
- Hanabayashi, Masahiro
- Yabe, Yuichiro
- Takagi, Hideki
- Oguchi, Takeshi
- Kato, Takefumi
- Funahashi, Koji
- Matsumoto, Takuya
- Ando, Masahiko
- Kuwatsuka, Yachiyo
- Tanaka, Eiichi
- Yasuoka, Hidekata
- Kaneko, Yuko
- Hirata, Shintaro
- Murakami, Kosaku
- Sobue, Yasumori
- Nishiume, Tsuyoshi
- Suzuki, Mochihito
- Yokota, Yutaka
- Terabe, Kenya
- Asai, Shuji
- Ishiguro, Naoki
- Kojima, Toshihisa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner
Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner
Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
The PTPN221858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
Rethink about the role of rheumatoid factor and anti-citrullinated protein antibody in rheumatoid arthritis
Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner
Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner
Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
The PTPN221858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
Rethink about the role of rheumatoid factor and anti-citrullinated protein antibody in rheumatoid arthritis
Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner
Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner
Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
The PTPN221858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
Rethink about the role of rheumatoid factor and anti-citrullinated protein antibody in rheumatoid arthritis
Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study